Imagene AI Raises $21.5M in Seed and Series A Funding

Imagene AI, a Tel Aviv, Israel-based precision oncology diagnosis company, raised $21.5m in funding.

Funding included:

  • Blumberg Capital has raised $3m in seed capital.
  • $18.5m Series A round, Larry Ellison, Dr. David Agus and Eyal Gura.

Imagine AI was established in 2020 by Shahar porat, Jonathan Zalach and Dean Bitan. The technology uses a digitized biopsy to perform real-time molecular analysis. This sets a new standard by increasing accuracy and decreasing the time to obtain results.
The company partners with world-class medical centers and pharmaceutical firms to improve the accuracy and accessibility of therapeutic decisions for patients suffering from cancer. They also profile patients for clinical trials and speed up drug development.

The products mentioned are for research purposes only. They will be subject to regulatory clearances in any applicable markets.

Get latest news from African Startup ecosystem

Latest stories

You might also like...